Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$233.49 USD
-8.76 (-3.62%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $233.88 +0.39 (0.17%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-7.58 | 6.08% |
Earnings Summary
For their last quarter, Madrigal Pharmaceuticals (MDGL) reported earnings of -$7.10 per share, beating the Zacks Consensus Estimate of $-7.55 per share. This reflects a positive earnings surprise of 5.96%. Look out for MDGL's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$7.58 per share, reflecting a year-over-year decrease of 41.95%.
Earnings History
Price & Consensus
Zacks News for MDGL
Viking Surges 342% in the Past Year: How Should You Play the Stock?
MDGL: What are Zacks experts saying now?
Zacks Private Portfolio Services